# Gyeongnam Venture Investment

> Gyeongnam Venture Investment is a VC fund backing Biotechnology. See 17 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 17
- Last investment: Dec 2025
- Lead investor: 12%
- Last updated: Aug 2026

Gyeongnam Venture Investment is a VC fund focused on Biotechnology and Manufacturing. Gyeongnam Venture Investment operates as an investment firm.

## Contacts

5 contacts available for Gyeongnam Venture Investment. Shizune tracks 1 team members at Gyeongnam Venture Investment. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/gyeongnam-venture-investment?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 18% |
| Manufacturing | 3 | 18% |
| Semiconductor | 3 | 18% |
| Robotics | 2 | 12% |
| Software | 2 | 12% |

33 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 8 | 47% |
| Seed | 7 | 41% |
| Series B | 1 | 6% |
| Venture - Series Unknown | 1 | 6% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kuk-hyeong Cho | CEO | 1 | https://shizune.co/investors/profile/cho-kuk-hyeong |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rovolution | Rovolution is a South Korean robotics and automation company developing advanced industrial robots, collaborative robot systems, and smart factory solutions. The company focuses on improving manufacturing efficiency, precision, and safety through AI-driven robotics, control systems, and integrated automation technologies for modern industries andproduction environments. RoboticsAI. | $1.4M | Seed | Dec 30, 2025 |  |
| MHS | MHS operates as a thermal management company specializing in cooling technology and thermal fluid analysis for high-heat environments. The company applies experience from multiple industries and knowledge of heatsink design to assess customer requirements and operating conditions at the design stage. It develops and provides thermal solutions forengineering applications. | $4.7M | Series A | Nov 24, 2025 |  |
| MHS | MHS actively responds to rapidly changing internal and external conditions and the technology development environment, and conducts various research and development in cooperation with customers based on our accumulated experience and know-how . MHS conduct consulting using a one-solution approach to ensure easy access for the clients. Theyprovide a service that assists in problem-solving from initial request to design, analysis, manufacturing, and results. By tailoring the specific characteristics of the client's desired field, the company offer the most economical and reasonable consulting solutions. | $3.6M | Series A | Aug 14, 2025 |  |
| ROBOS | Robos is a hybrid robot system built by evaluating biological object vision data using Lidar Vision and Open CV-based Object Detection. By combining self-developed biomaterial machine vision technology and robot technology, it intends to expand into a company that delivers core services to diverse industrial sites such as manufacturing, food, andmedical. | $5.2M | Series A | Feb 13, 2024 |  |
| Rebellions | AI chip architects are often inattentive to advanced deep learning features and requirements because they believe software stacks between their silicon and algorithms can provide effective abstract layers. We disagree. We do not think such naively designed chips can efficiently utilize expensive custom silicon resources. The more native hardwaresupports are enabled, the higher performance is achieved.Rebellions Inc is building genuine AI accelerators by bi-directionally bridging the gap between underlying silicon architectures and deep learning algorithms. We push algorithm boundaries to better exploit silicon budgets, while re-architecting AI processors to incorporate sophisticated deep learning features through silicon-dedicated DL kernels.Our goal is to deliver a domain-specific AI processor along with its optimized software. This approach, together with our unique decentralized programming model, will enable customers to arm with the most powerful yet energy-efficient AI hardware as well as seamless integration. | $123.7M | Series B | Jan 29, 2024 |  |
| KRISTIN | KRISTIN is a supplier of flat, sneakers, and boots. | $5.3M | Series A | Nov 10, 2023 |  |
| Reset Company | Reset Company specializes in building sustainable energy production and resource circulation ecosystems. | $2.2M | Series A | Oct 05, 2023 |  |
| Santa | Santa is pushing content creation to new limits. Didicast, an easy to use video editing software developed by Santa, is made for content creators that are determined to produce polished videos for anything from education to entertainment. By leveling the learning curve and throwing out the expenses required in traditional content creation, Santa ishelping creators from around the world change the world. |  | Series A | Aug 22, 2023 |  |
| Biome ATS | BioM ATS intends to provide the fundamental infrastructure required to progress the complex strain design platform and foster technical collaboration with microbiome firms through proof-of-concept (POC) of the complex strain design technology. It is a strategy to begin the platform business in earnest by the end of the year, with an emphasis onplatform advancement and collaboration with industry, academia, research institutes, and the military. | $1.5M | Seed | Jun 28, 2023 |  |
| Biomatz | Biomatz is a biotechnology company specializing in microbiome therapeutics. Their proprietary platform designs cooperative microbial consortia by isolating and analyzing complex gut microbiota interactions, facilitating the development of live biotherapeutic products. It aims to advance personalized medicine and gut health solutions withapplications spanning pharmaceuticals, nutraceuticals, and functional foods.​ | $1.5M | Seed | Jun 28, 2023 |  |

10 of 17 investments shown.

## Co-investors
- [Aju IB Investment](https://shizune.co/investors/profile/aju-ib-investment) — VC Fund, 3 deals together
- [Shinhan Venture Investment](https://shizune.co/investors/profile/shinhan-venture-investment) — VC Fund, 3 deals together
- [Daewoong Pharmaceutical](https://shizune.co/investors/profile/daewoong-pharmaceutical) — VC Fund, 2 deals together
- [Dt& Investment](https://shizune.co/investors/profile/dt-investment) — VC Fund, 2 deals together
- [Korea Investment Partners](https://shizune.co/investors/profile/korea-investment-partners) — VC Fund, 2 deals together
- [Korea Kolmar Co.](https://shizune.co/investors/profile/korea-kolmar-co) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in South Korea](https://shizune.co/investors/health-care-vc-funds-south-korea)
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)
- [Biotech Investors in South Korea](https://shizune.co/investors/biotech-investors-south-korea)
- [Biotech VC Funds in South Korea](https://shizune.co/investors/biotech-vc-funds-south-korea)
- [Manufacturing Investors in South Korea](https://shizune.co/investors/manufacturing-investors-south-korea)
- [Biotechnology Investors in South Korea](https://shizune.co/investors/biotechnology-investors-south-korea)

## FAQ

### What does Gyeongnam Venture Investment invest in?

Gyeongnam Venture Investment invests primarily in Biotechnology, Manufacturing and Semiconductor startups, most often at Series A and Seed stage. Most of the 17 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Gyeongnam Venture Investment?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Gyeongnam Venture Investment?

The team at Gyeongnam Venture Investment includes Kuk-hyeong Cho (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co